Author: A. Ant, CADC-II, Licensing & Accreditation Expert
Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.
Apply now: DOH Division of Certificate of Need and Licensing (CN&L) | Questions: cnandlicensingrequests@doh.nj.gov
“Inpatient” mental health in New Jersey covers two very different things, and they are licensed on different tracks. Community residences for adults with mental illness (supervised group homes, supervised apartments, family care homes and shared supportive housing) fall under N.J.A.C. 10:37A, Licensed Community Residences for Adults with Mental Illnesses. The rule itself says these residences are not health care facilities under N.J.S.A. 26:2H. Psychiatric hospitals and psychiatric beds are a hospital-level license, and new psychiatric beds go through full Certificate of Need review. Both are licensed by the Department of Health, Division of Certificate of Need and Licensing (CN&L). Most of this guide deals with community residences, with a section on psychiatric beds further down. Neither one is part of the 2026 outpatient overhaul.
Why the Department of Health, Not DMHAS, Issues These Licenses
DMHAS still gets treated as the licensing agency more often than it should. Two reorganization plans produced the current split. In the first, No. 001-2017 (effective August 28, 2017), the Department of Health absorbed DMHAS along with mental health and SUD licensing and inspection. The second, No. 001-2018 (effective August 20, 2018), handed DMHAS back to Human Services and let the Department of Health hold on to the licensing work. DMHAS remains the state mental health authority, and the facility license, community residence licenses included, comes from DOH. Under the 2024 readoption of 10:37A, the provider agency applies to DOH, DOH issues the license, and inquiries go to CN&L at PO Box 358, Trenton, NJ 08625-0358. Licenses for supervised apartments and for shared supportive housing run two years. Programs accredited within the past three years by a body DOH recognizes (the rule names the Joint Commission, COA, CARF and NCQA) can have that deemed status considered at the triennial program review, which can stand in for some of the state’s own program standards.
Residential Mental Health Sits Outside the New Integrated License
These two reforms sound related, but one has absolutely no bearing on residential licensure. New Jersey’s 2026 integrated license reform, N.J.A.C. 8:43K (effective April 6, 2026), lets one license cover outpatient mental health, SUD treatment, opioid treatment, and primary care services together. Its scope is outpatient and integrated care facilities. Residential community residences for adults with mental illness stay under their own standalone chapter, N.J.A.C. 10:37A, unaffected by the outpatient consolidation, the same way residential SUD treatment stays under N.J.A.C. 8:111 (formerly 10:161A) rather than folding into 8:43K.
Psychiatric Hospitals and Psychiatric Beds
If your project is a true inpatient psychiatric service, the 10:37A community residence path does not apply. DOH’s licensure application for hospital-level facilities, form CN-7 (Application for New or Amended Acute Care Facility License), lists Psychiatric Hospital as its own category and asks for the completed application 45 days before the planned opening. Before that, there is a bigger hurdle. DOH’s Certificate of Need page puts psychiatric beds on the full review list, which means review by the State Health Planning Board, not the expedited track. The same page links a CN call for adult psychiatric beds, so check whether a call is open before you build a schedule around a filing date. Plan for the CN decision before you commit to construction.
Ketamine for Residents and Psychiatric Inpatients in New Jersey
Neither N.J.A.C. 10:37A nor DOH’s hospital licensing materials address ketamine. The split below between community residences and psychiatric hospitals is our reading of the medication and pharmacy rules we cite.
The two license types on this page give very different answers. A community residence is housing with rehabilitation support, and the medication rule shows it. Under N.J.A.C. 10:37A-6.4, residents “shall self-administer” their own medication to the extent possible, staff may assist and supervise that self-administration, and “appropriately licensed or certified staff must administer medication” only when a resident can’t manage it even with verbal help. Nothing in that rule contemplates an infusion or a monitored nasal dose on site. A resident of a supervised group home or apartment who is a good candidate for ketamine gets it at an outside clinic or hospital program, and the residence’s part is transportation, a ride home and someone checking in that evening. Write that coordination into the rehabilitation plan so staff know what they are and aren’t responsible for.
Psychiatric Hospitals and Units
A licensed psychiatric hospital is the setting where ketamine can be started under the same roof as the patient’s other care. The decision runs through the hospital’s own structure. For Medicare-participating hospitals, 42 CFR 482.25 requires a formulary system “established by the medical staff,” records of the receipt and disposition of all scheduled drugs, and medical staff policies to minimize drug errors. In practice that means the pharmacy and therapeutics process adds ketamine (or esketamine) to the formulary, the medical staff grants privileges to the psychiatrists who will order it, and nursing writes a monitoring protocol. If the hospital uses Spravato, it must be certified in the Spravato REMS and monitor each patient for at least two hours after the dose. Ketamine itself is Schedule III (21 CFR 1308.13(c)(7)), and the hospital’s New Jersey CDS registration has to sit at the same address as its DEA registration.
Patients held on involuntary commitment raise a consent question we would not try to answer on a general page. An off-label treatment like ketamine for depression belongs with patients who can give informed consent, and hospital counsel should sign off before any committed patient is considered.
Planning the Outpatient Handoff at Admission
A psychiatric stay is short, and a ketamine series usually is not. Decide at admission, not at discharge, which outpatient practice will take over the series, get the patient’s written consent to share records with it, and send the dosing history and response notes with the discharge summary. New Jersey requires that practice to be owned by licensed health care professionals (N.J.A.C. 13:35-6.16(e)), and the ownership and registration steps for a stand-alone clinic are in the ketamine section of New Jersey Drug and Alcohol Outpatient Treatment Licensing.
Staffing a Residential Mental Health Program
Acuity, not program size, drives the real staffing bar for residential mental health care. 10:37A sets some of the floor directly: a registered nurse (or higher-level nursing professional) completes a face-to-face assessment by the 14th day after admission and visits every 90 days after that, each rehabilitation plan is signed by a physician or other licensed practitioner authorized to recommend treatment, residents need 24/7 access to an on-call staff member, and Level A+ residences carry awake overnight staff. In our experience, most operators also add a clinical director and a standing prescriber relationship on top of that. New Jersey’s substance abuse, behavioral disorder, and mental health counselors and clinicians earn a median of $64,710 a year statewide (BLS OEWS, May 2024), several thousand dollars over the roughly $59,350 national figure, so a program with a clinical director, several clinicians, and 24-hour direct-care coverage commonly runs well past $500,000 a year in payroll before prescriber and nursing costs. It is a high bar, though a well-structured roster can carry it. Mental health clinicians in New Jersey are licensed through their own respective boards, separate from the Alcohol and Drug Counselor Committee of the State Board of Marriage and Family Therapy Examiners, which handles addiction counselor credentials, and many programs pair a fully licensed clinical director with associate-level clinicians completing their own supervised hours, which keeps a meaningful share of payroll below what an all-independently-licensed roster would cost, while pairing one RN with several LPNs for medical oversight rather than staffing every shift with a registered nurse. The full matrix gets drafted after census and program type are pinned down.
What Delays New Jersey Residential Mental Health Projects
A small number of mistakes drive most of the real delays on these projects. The most common delay is confusing N.J.A.C. 10:37A’s community residence standards with the 2026 outpatient integrated license, assuming reforms that touched outpatient care also changed residential requirements when they didn’t. The second is sending the application to DMHAS when it belongs with DOH’s Division of Certificate of Need and Licensing. A third shows up on psychiatric projects: owners who budget for a licensing review and only later learn that new psychiatric beds need a full Certificate of Need first.
Frequently Asked Questions
What timeline should a New Jersey community residence or psychiatric bed project expect?
Our planning estimate is roughly 12 to 18 months for a community residence licensed under N.J.A.C. 10:37A, covering staffing, policy development, and DOH’s licensing review. No rule sets that timeline. A psychiatric bed project usually runs longer because the Certificate of Need comes first.
Did New Jersey’s 2026 integrated license reform change residential mental health licensing?
No. N.J.A.C. 8:43K applies to outpatient and integrated care facilities. Residential community residences for adults with mental illness stay under their own separate chapter, N.J.A.C. 10:37A.
Who licenses residential mental health programs in New Jersey?
DOH’s Division of Certificate of Need and Licensing issues the license, not DMHAS. Under N.J.A.C. 10:37A the provider agency applies to DOH, and psychiatric hospitals are licensed by DOH as well.
Confirming whether DOH or DMHAS handles your New Jersey application? Reach out here.
Sources
- N.J. Department of Human Services, N.J.A.C. 10:37A rule text: Licensed Community Residences for Adults with Mental Illnesses (checked October 8, 2026)
- N.J. Department of Human Services, N.J.A.C. 10:37A readoption, 56 N.J.R. 901(a): Notice of Readoption with Technical Changes (checked October 8, 2026)
- N.J. Department of Health, N.J.A.C. 8:43K: Notice of Adoption, Outpatient and Integrated Care Facilities (checked October 8, 2026)
- N.J. Department of Health, N.J.A.C. 8:43K proposal, 57 N.J.R. 743(a): Notice of Proposal (scope and Reorganization Plans 001-2017 and 001-2018) (checked October 8, 2026)
- N.J. Department of Health, 10:161A recodified as N.J.A.C. 8:111, 53 N.J.R. 12(2): Notice of Readoption and Recodification (checked October 8, 2026)
- N.J. Department of Health: Certificate of Need (checked October 8, 2026)
- N.J. Department of Health, form CN-7: Application for New or Amended Acute Care Facility License (checked October 8, 2026)
- N.J. Department of Health: Health Facilities contacts (CN&L intake email and mailing address) (checked October 8, 2026)
- N.J. Department of Human Services: Division of Mental Health and Addiction Services (checked October 8, 2026)
- N.J.A.C. 13:34C-1.2, definitions (Justia mirror of official text): Alcohol and Drug Counselor Committee (checked October 8, 2026)
- N.J. Division of Consumer Affairs: Professional and Occupational Boards and Committees (checked October 8, 2026)
- eCFR, 21 CFR 1308.13(c)(7): ketamine as a Schedule III depressant (checked October 9, 2026)
- U.S. FDA: Spravato prescribing information and Medication Guide, REMS and two-hour monitoring (checked October 9, 2026)
- N.J.A.C. 10:37A-6.4 (Justia mirror of official text): Medication in community residences (checked October 9, 2026)
- eCFR, 42 CFR 482.25: Hospital pharmaceutical services, formulary and scheduled drug records (checked October 9, 2026)
- N.J. Division of Consumer Affairs: CDS registration FAQ (checked October 9, 2026)
- N.J.A.C. 13:35-6.16 (Justia mirror of official text): Professional practice structure (checked October 9, 2026)

Leave a Reply